Categories: News

ChipSync Acquires U.S.-Based Mobimark Labs to Strengthen Leadership in Automotive Audio Quality Certifications

BANGALORE, India and MYSURU, India, Oct. 27, 2025 /PRNewswire/ — ChipSync, a leading innovator in Connected Car Technology and advanced automotive solutions, has announced the acquisition of Meridian America LLC (a.k.a Mobimark Labs), a specialized automotive audio quality testing provider for industry standard certifications based in Los Angeles, California, USA.

- Advertisement -

Mobimark Labs has earned a strong reputation as a niche leader in audio and acoustics optimization and certification testing, including full compliance with ITU-T standards. Leveraging its state-of-the-art testing facilities and highly specialized engineering team, Mobimark Labs has supported leading automotive OEMs and Tier-1 suppliers worldwide to deliver high-fidelity, certified infotainment experiences.

- Advertisement -

“This acquisition represents a strategic leap forward for ChipSync,” said Hariprasad KB, CEO of ChipSync. “As vehicles become increasingly connected and user experience takes center stage, Mobimark Labs’ deep expertise in acoustic tuning and smartphone connected in-vehicle infotainment system certification purpose testing will enable us to integrate critical testing and compliance capabilities directly into our automotive platforms. Together, we’ll empower automakers to bring immersive, certified infotainment systems to market faster than ever.”

- Advertisement -

Mobimark Labs’ cutting-edge expertise in audio measurement, acoustic testing and ITU-T compliance processes will be seamlessly integrated into ChipSync’s automotive solutions portfolio, positioning the company as a one-stop global leader in connected infotainment technologies.

- Advertisement -

About ChipSync

- Advertisement -

Headquartered in Mysuru, India, ChipSync (www.chipsynctech.com) is a global technology company specializing in building high quality software products and solutions for automakers and consumers across the world. ChipSync‘s expertise is in automotive software development with primary focus on in-vehicle infotainment, connected car technology, security and semiconductor solutions. ChipSync’s products power intelligent devices and connected vehicles around the world.

- Advertisement -

About Mobimark Labs

- Advertisement -

Based in Los Angeles, CA., USA, Meridian America LLC (a.k.a Mobimark Labs) provides automotive audio testing and pre-testing for certification purpose for OEMs and Tier-1 suppliers. The company focuses on ITU-T standard testing and is recognized for its precision acoustics work in infotainment system certification.

- Advertisement -

For media inquiries, please contact:

hari@chipsynctech.com

syed.kalam@chipsynctech.com

- Advertisement -

Logo: https://mma.prnewswire.com/media/2796928/5564076/ChipSync_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/chipsync-acquires-us-based-mobimark-labs-to-strengthen-leadership-in-automotive-audio-quality-certifications-302595261.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

2 hours ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

6 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

6 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

6 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

6 hours ago